| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | -10.287 | -19.286 | -2.457 | -0.072 |
| Debt to Asset Ratio | 12.192 | 8.041 | 9.81 | 15.415 |
| Cash Ratio | 114.118 | 146.07 | 140.245 | 98.314 |
| Quick Ratio | 897.059 | 1,325.349 | 1,090.47 | 648.734 |
| Current Ratio | 897.059 | 1,325.349 | 1,090.47 | 648.734 |
Spyre Therapeutics, Inc. (SYRE)
Spyre Therapeutics, Inc. (SYRE)